Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...

SINGAPORE – A French pharmaceutical giant has opened a new $800 million manufacturing facility in Tuas Biomedical Park ... in Singapore – will produce vaccines and other biopharmaceutical ...

GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...

GSK has received European Commission approval for a fully liquid, single-vial version of Menveo, its MenACWY vaccine for invasive meningococcal disease, it announced on Wednesday. The FTSE 100 ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

(Sharecast News) - GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process against invasive meningococcal disease (IMD).

Experts worry that the unenthusiastic embrace of vaccines could spark outbreaks and increased hospitalizations. As of this month, about 37 percent of adults 18 and older had received a seasonal ...

A motorcyclist had a close call after a container truck almost completely ran the rider and his two-wheeler over at the junction of Tuas West and Tuas Link 4. A video posted to social media showed ...

Arexvy is an RSV vaccine currently authorised in the US and a further 35 countries. Credit: MargJohnsonVA/Shutterstock. GlaxoSmithKline (GSK) has received approval ...

The vaccine's active ingredient is a recombinant RSV glycoprotein F stabilised in the prefusion conformation (RSVPreF3), combined with GSK's AS01 E adjuvant. This adjuvant system includes STIMULON ...